Will imaging individual raphe nuclei in males with major depressive disorder enhance diagnostic sensitivity and specificity?
Depression and Anxiety Feb 08, 2018
Pillai RLI, et al. - Researchers sought to identify 5-HT1A differences in individual raphe nuclei using positron emission tomography (PET) in order to determine whether use of subnuclei would provide greater sensitivity and specificity of diagnosing major depressive disorder (MDD). In MDD, higher 5-HT1A autoreceptor binding was observed selectively in the dorsal raphe nucleus (DRN). They found that 5-HT1A autoreceptor binding in the combined DRN and median raphe nucleus (MRN) was a better biomarker for MDD than in the raphe as a whole.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries